Avacta Share Discussion Threads

[babbler] 10/10/2019 08:12

Nice slow re-rate back into 30s...doing what mtfb should have.

[toffeeman] 10/10/2019 08:12

will need more of these to get a decent lift

[genierub] 10/10/2019 08:08

No quote given on buying. Extremely positive sign for where this could be heading.

[bumpa33] 10/10/2019 07:20

Collab with a $1.6B Pharma, Swiss ADC Therapeutics.

[chilly0] 08/10/2019 22:42

AGM soon. That will be fun ?

[chilly0] 08/10/2019 22:41

Well it plain to see. Risky share

[escapetohome] 08/10/2019 22:27

Avacta: An unacceptable performance.

I dont mince words.

[chilly0] 08/10/2019 22:25

Well done you deserve a break

[dave4545] 25/9/2019 08:52

Interesting chart.

No move and at a critical level. If it starts to move up from here then it could really bounce well. But if it dropped below 20p then the chart looks poor.

mm's want almost full offer to buy though so strong online, it got chased into the 40's earlier this year.

If it goes blue I'll take a position

[danatkins] 12/9/2019 15:35

I also think we will have material news before the proverbial begging bowl comes out. Our CEO also mentioned raising money from Asia and I got the impression he was not happy with last round of finance. Of course take that as it is a large pinch of salt

[daymer58] 12/9/2019 14:54

AgreeHowever we must remember existing license deal have further payment in stages and the company did mentioned " new discussions " Still think the sector is grossly oversold and stocks like Avacta with a unique accelerated pipeline will start to attract some new institutional shareholders.Read across valuation of US biotech oncology stocks vs Avacta makes it ridiculous cheap and as a shareholder alas also a bid target.Roche, Novartis etc are all moving inAsians are signing deals, we got LG , who's next

[the drewster] 12/9/2019 13:38

The risk remains cash management ... value inflection points mean nothing if you have to go begging to the institutions for more cash, which they will dictate the terms on, not the company.

[escapetohome] 12/9/2019 13:14

Good sum up.

No way they are getting my shares at this price!

Keep trying , I doubt youre getting many.

[daymer58] 12/9/2019 12:56

Big move in the US Biotech/ health care sector last night.Goldman's strong upgrade in Bicycle Therapeutics 99% upside, stock moved 28%.Very good read across to AVCT . Expect further moves in the Antibody mimetic platform sector.We got two US IPO's in the oncology sector coming up, expect further deals from AVCT, the majors are all over this sector, stock massively oversold.

[danatkins] 12/9/2019 00:41

Tony I think you are a wiser individual. Company has no control over the share price. Biotech have been hit hard the last few years. look at etf labu says it all. the co is in easily stage development with risk attached same as all biotech companies

[lantanatony] 11/9/2019 22:00

Sorry typo should read "without so much as a comment "

[lantanatony] 11/9/2019 21:33

Avacta keep saying to their Share holders how pleased they are to have attracted such a strong Board.
Well it seems to me that this Board is failing the Company and its Shareholders!?
Why is a Public Company allowed to sit back and let it's Shares get to 0.2 pence in old money with so much as a comment?
Poor form in my humble opinion.

[losses] 11/9/2019 14:19

Added more to portfolio for my sins lol